Chlorethylaminouracil - analogs
Pharmgroups: Antimetabolites |
|||||||||
| Prices in pharmacies: Instructions Chlorethylaminouracil | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 75% Paphencyl
- 73% Cytarabine
- 70% Fludarabine
- 67% Mercaptopurine
- 64% Lophenalac
- 59% Ibrutinib
- 59% Tioguanine
- 50% Prodimin
- 47% Rufocromomycin
- 45% Imatinib
- 44% Nelarabine
- 42% Pumitepa
- 41% Venetoclax
- 41% Lipegfilgrastim
- 40% Akalabrutinib
- 40% Bosutinib
- 39% Hydroxycarbamide
- 35% Busulfan
- 35% Amsacrine
- 33% Dasatinib
- 33% Dipin
- 31% Asparaginase
- 28% Bleomycin
- 28% Daunorubicin
- 27% Pegaspargase
- 26% Raltitrexed
- 25% Nitrosomethylurea
- 24% Tegafur+Uracil [Tegafur]
- 24% Tegafur+Gimeracil+Oteracil [Tegafur]
- 24% Immunoglobulin human normal
- 23% Procarbazine
- 23% Lenograstim
- 23% Vindesine
- 22% Dibrospidium chloride
- 21% Febuxostat
- 21% Teniposide
- 21% Idarubicin
- 21% Chlorambucil
- 21% Fotretamine
- 20% Epoetin alfa
- 20% Cyclophosphamide
- 20% Carubicin
- 20% Hexaphosphamide
- 20% Obinutuzumab
- 20% Ofatumumab
- 19% Topotecan
- 18% Methotrexate
- 17% Lorlatinib
- 17% Pembrolizumab
- 17% Inotuzumab ozogamicin
Learn more about the selection of analogues
- The drug has «Chlorethylaminouracil» no complete analogues; 51 analog by action, the most similar - Paphencyl .
- Medical online service has selected the best substitutes for Chlorethylaminouracil based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Chlorethylaminouracil to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.